Interpretation Response #PI-95-030
Below is the interpretation response detail and a list of regulations sections applicable to this response.
Interpretation Response Details
Response Publish Date:
Company Name:
Individual Name:
Country: US
View the Interpretation Document
Response text:
Date: July 28, 1995
Reply to Attn of: Jim Swart X63784
Subject: Action: NTSB Recommendation
From: Albert Alvarez, Director
Office of Drug Enforcement and Program Compliance
To: Drug & Alcohol Program Managers
As a result of a National Transportation Safety Board recommendation to the Department regarding the on-duty use of medication by safety-sensitive employees in the transportation industries, operating administrations are asked to provide the widest dissemination possible for the following statement:
The U.S. Department of Transportation (DOT) reminds all transportation industries of the potential threat to public safety caused by the on-duty use of some over-the-counter and prescription medications by persons performing safety sensitive duties. As a result, we strongly urge all transportation industry employers to include in their employee training materials appropriate information to address this issue. We also encourage employers to reiterate with their employees the need to report use of such medications when required by applicable DOT rules or by company policies.
Your efforts to make this statement available throughout your regulated industry are appreciated.